
Am J Psychiatry 160:112-117, January 2003
© 2003 American Psychiatric Association
Obesity as a Correlate of Outcome in Patients With Bipolar I Disorder
Andrea Fagiolini, M.D.,
David J. Kupfer, M.D.,
Patricia R. Houck, M.S.H.,
Danielle M. Novick, B.A., and
Ellen Frank, Ph.D.
OBJECTIVE: This study sought to evaluate the relationship of obesity to demographic and clinical characteristics and treatment outcome in a group of 175 patients with bipolar I disorder who were treated for an acute affective episode and followed through a period of maintenance treatment. METHOD: Data were from participants entering the Maintenance Therapies for Bipolar Disorder protocol between 1991 and 2000. Analyses focused on differences in baseline demographic and clinical characteristics and in treatment outcomes between obese and nonobese patients. RESULTS: A total of 35.4% of the patients met criteria for obesity. Significant differences between the obese and nonobese patients were observed for years of education, numbers of previous depressive and manic episodes, baseline scores on the Hamilton Rating Scale for Depression, and durations of the acute episode. A Kaplan-Meier survival analysis indicated a significantly shorter time to recurrence during the maintenance phase among obese patients. The number of patients experiencing a depressive recurrence was significantly higher in the obese than in the nonobese group. CONCLUSIONS: Obesity is correlated with a poorer outcome in patients with bipolar I disorder. Preventing and treating obesity in bipolar disorder patients could decrease the morbidity and mortality related to physical illness, enhance psychological well-being, and possibly improve the course of bipolar illness. Weight-control interventions specifically designed for patients with bipolar illness should be developed, tested, and integrated into the routine care provided for these patients.
This article has been cited by other articles:

|
 |

|
 |
 
D. T. Plante and J. W. Winkelman
Sleep Disturbance in Bipolar Disorder: Therapeutic Implications
Am J Psychiatry,
July 1, 2008;
165(7):
830 - 843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Simmons-Alling and S. Talley
Bipolar Disorder and Weight Gain: A Multifactorial Assessment
Journal of the American Psychiatric Nurses Association,
January 1, 2008;
13(6):
345 - 352.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Bowden, J. R. Calabrese, T. A. Ketter, G. S. Sachs, R. L. White, and T. R. Thompson
Impact of Lamotrigine and Lithium on Weight in Obese and Nonobese Patients With Bipolar I Disorder
Am J Psychiatry,
July 1, 2006;
163(7):
1199 - 1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zvonic, A. A. Ptitsyn, S. A. Conrad, L. K. Scott, Z. E. Floyd, G. Kilroy, X. Wu, B. C. Goh, R. L. Mynatt, and J. M. Gimble
Characterization of peripheral circadian clocks in adipose tissues.
Diabetes,
April 1, 2006;
55(4):
962 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A Marken and R. W Pies
Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles
Ann. Pharmacother.,
February 1, 2006;
40(2):
276 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Morriss and F. A. Mohammed
Metabolism, lifestyle and bipolar affective disorder
J Psychopharmacol,
November 1, 2005;
19(6_suppl):
94 - 101.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. McIntyre and J. Z. Konarski
Obesity and Psychiatric Disorders: Frequently Encountered Clinical Questions
Focus,
October 1, 2005;
3(4):
511 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Kupfer
The Increasing Medical Burden in Bipolar Disorder
JAMA,
May 25, 2005;
293(20):
2528 - 2530.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vreeland and E. Kim
Managing the Clinical Consequences of Psychiatric Illness and Antipsychotic Treatment: A Discussion of Obesity, Diabetes, and Hyperprolactinemia
Journal of the American Psychiatric Nurses Association,
June 1, 2004;
10(3_suppl):
S17 - S24.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M Woods, S. F Eichner, and A. S Franks
Weight Gain Mitigation with Topiramate in Mood Disorders
Ann. Pharmacother.,
May 1, 2004;
38(5):
887 - 891.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|